(Q35214553)

7 August 2017

1 reference

title

Telmisartan/hydrochlorothiazide: in the treatment of essential hypertension (English)

1 reference

7 August 2017

3

Lesley J Scott

1 reference

7 August 2017

2

Gillian M Keating

1 reference

7 August 2017

Caroline Fenton

1

1 reference

7 August 2017

publication date

1 January 2003

1 reference

7 August 2017

1 reference

7 August 2017

volume

63

1 reference

7 August 2017

issue

19

1 reference

7 August 2017

page(s)

2013-26; discussion 2027-8

1 reference

Long-term exposure to telmisartan as monotherapy or combination therapy: efficacy and safety

7 August 2017

cites work

1 reference

12 December 2020

Large differences in the biological half-life and volume of distribution of hydrochlorothiazide in normal subjects from eleven studies. Correlation with their last blood sampling times

1 reference

12 December 2020

Effects of telmisartan, hydrochlorothiazide and their combination on blood pressure and renal excretory parameters in spontaneously hypertensive rats

1 reference

12 December 2020

Combination treatment with telmisartan and hydrochlorothiazide in black patients with mild to moderate hypertension

1 reference

12 December 2020

A new fixed-dose combination for added blood pressure control: telmisartan plus hydrochlorothiazide

1 reference

12 December 2020

Inhibition of carbonic anhydrase accounts for the direct vascular effects of hydrochlorothiazide

1 reference

12 December 2020

Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial

1 reference

12 December 2020

Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients

1 reference

12 December 2020

Efficacy and tolerability of a fixed-dose combination of telmisartan plus hydrochlorothiazide in patients uncontrolled with telmisartan monotherapy

1 reference

12 December 2020

Evaluation of the safety and efficacy of telmisartan and enalapril, with the potential addition of frusemide, in moderate-renal failure patients with mild-to-moderate hypertension

1 reference

12 December 2020

Hemodynamic changes during long-term thiazide treatment of essential hypertension in responders and nonresponders

1 reference

12 December 2020

Pharmacokinetics of hydrochlorothiazide in relation to renal function

1 reference

12 December 2020

Pharmacokinetics of hydrochlorothiazide in patients with congestive heart failure

1 reference

12 December 2020

Pharmacokinetics and safety of intravenous and oral telmisartan 20 mg and 120 mg in subjects with hepatic impairment compared with healthy volunteers

1 reference

12 December 2020

The telmisartan Programme of Research tO show Telmisartan End-organ proteCTION (PROTECTION) Programme

1 reference

12 December 2020

Multiple-dose pharmacokinetics of telmisartan and of hydrochlorothiazide following concurrent administration in healthy subjects.

1 reference

12 December 2020

Racial differences in response to acute dosing with hydrochlorothiazide

1 reference

12 December 2020

Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. TEES Study Group.

1 reference

12 December 2020

Comparison of 26-week efficacy and tolerability of telmisartan and atenolol, in combination with hydrochlorothiazide as required, in the treatment of mild to moderate hypertension: a randomized, multicenter study

1 reference

12 December 2020

Long-term efficacy and tolerability of telmisartan as monotherapy and in combination with other antihypertensive medications

1 reference

12 December 2020

Bioavailability of hydrochlorothiazide from tablets and suspensions

1 reference

12 December 2020

Pharmacokinetics of hydrochlorothiazide in fasted and nonfasted subjects: a comparison of plasma level and urinary excretion methods.

1 reference

12 December 2020

Pharmacokinetics of single-dose telmisartan 120 mg given during and between hemodialysis in subjects with severe renal insufficiency: comparison with healthy volunteers

1 reference

12 December 2020

Efficacy and tolerability of fixed-dose combinations of telmisartan plus HCTZ compared with losartan plus HCTZ in patients with essential hypertension

1 reference

12 December 2020

Thiazide-induced vasodilation in humans is mediated by potassium channel activation

1 reference

12 December 2020

Inhibitory effect of telmisartan on the blood pressure response to angiotensin II challenge

1 reference

12 December 2020

Telmisartan: a review of its use in hypertension

1 reference

12 December 2020

In vitro and in vivo characterization of the activity of telmisartan: an insurmountable angiotensin II receptor antagonist

1 reference

12 December 2020

Absorption, metabolism, and excretion of intravenously and orally administered [14C]telmisartan in healthy volunteers

1 reference

12 December 2020

Comparison of a fixed-dose combination of 40 mg telmisartan plus 12.5 mg hydrochlorothiazide with 40 mg telmisartan in the control of mild to moderate hypertension

1 reference

12 December 2020

Angiotensin II receptor blockade: is there truly a benefit of adding an ACE inhibitor?

1 reference

12 December 2020

Pharmacokinetics of hydrochlorothiazide in man

1 reference

12 December 2020

Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery

1 reference

12 December 2020

10.2165/00003495-200363190-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

7 August 2017

1037759088

0 references

1 reference